| Symbol | Company | Weighting |
|---|---|---|
| PSNL | PERSONALIS | 3.54% |
| WGS | GENEDX HLDGS CORP NPV | 3.10% |
| HTFL | HEARTFLOW INC | 2.90% |
| SGMT | SAGIMET BIOSCIENCES INC | 2.56% |
| RGEN | REPLIGEN CORP | 2.33% |
| ICLR | ICON PLC | 2.29% |
| IMVT | IMMUNOVANT INC | 2.19% |
| EWTX | EDGEWISE THERAPEUTICS | 2.17% |
| THC | TENET HEALTHCARE CORP | 2.14% |
| PVLA | PALVELLA THERAPEUTICS, INC. | 2.11% |
| RVMD | REVOLUTION MEDICINES INC | 2.09% |
| HUM | HUMANA INC | 1.99% |
| WAT | WATERS CORP | 1.98% |
| MRK | MERCK & CO. NEW | 1.94% |
| DGX | QUEST DIAGNOSTICS | 1.91% |
| DXCM | DEXCOM INC | 1.89% |
| HIMS | HIMS & HERS HEALTH, INC. | 1.88% |
| ARQT | ARCUTIS BIOTHERAPEUTICS | 1.88% |
| PCVX | VAXCYTE INC | 1.87% |
| KRYS | KRYSTAL BIOTECH INC | 1.86% |
| MCK | MCKESSON CORP | 1.86% |
| LH | LABCORP HOLDINGS INC | 1.85% |
| DHR | DANAHER CORP | 1.84% |
| BDX | BECTON DICKINSON & CO | 1.82% |
| INSM | INSMED INC | 1.82% |
| ABBV | ABBVIE INC | 1.80% |
| DNLI | DENALI THERAPEUTICS INC. | 1.79% |
| MDT | MEDTRONIC PLC | 1.78% |
| ABT | ABBOTT LABORATORIES | 1.77% |
| LLY | ELI LILLY CORP | 1.77% |
| ACHC | ACADIA HEALTHCARE CO INC | 1.76% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.75% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.71% |
| RCUS | ARCUS BIOSCIENCES INC | 1.67% |
| MLYS | MINERALYS THERAPEUTICS I | 1.67% |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | 1.62% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.60% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1.60% |
| CVS | CVS HEALTH CORPORATION | 1.54% |
| AVTX | AVALO THERAPEUTICS INC | 1.52% |
| TSHA | TAYSHA GENE THERAPIES I | 1.49% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.44% |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1.43% |
| ZTS | ZOETIS INC | 1.43% |
| UNH | UNITEDHEALTH GROUP INC | 1.42% |
| NVS | NOVARTIS AG-ADR | 1.41% |
| IDXX | IDEXX LABS CORP | 1.35% |
| SYK | STRYKER CORP | 1.34% |
| UTHR | UNITED THERAPEUTICS CORPS | 1.33% |
| AZN | ASTRAZENECA PLC | 1.30% |
| PODD | INSULET CORP | 1.29% |
| ISRG | INTUITIVE SURGICAL INC | 1.19% |
| BSX | BOSTON SCIENTIFIC | 1.17% |
| IONS | IONIS PHARMACEUTICALS INC | 1.12% |
| SPRY | ARS PHARMACEUTICALS | 1.02% |
| OCS | OCULIS HOLDING AG | 0.58% |
| EYPT | EYEPOINT INC | 0.55% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) <a href="/services/prospectuses-and-reports">click here</a> or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Private Investments, LLC, Guggenheim Investments Loan Advisors, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.
